A novel deletion downstream of the PAX6 gene identified in a Chinese family with congenital aniridia.

Xiaoqi Liu,Yaqi Wu,Zequn Miao,Houbin Zhang,Bo Gong,Xianjun Zhu,Lulin Huang,Yi Shi,Fang Hao,Shi Ma,He Lin,Lejin Wang,Zhenglin Yang
DOI: https://doi.org/10.1080/13816810.2018.1466336
2018-01-01
Ophthalmic Genetics
Abstract:Purpose: Congenital aniridia, a severe bilateral panocular visual disorder, is an autosomal dominantly inherited eye anomaly. Mutations in the paired box 6 gene (PAX6) have been shown to be responsible for congenital aniridia in most patients. The purpose of the present study was to report clinical features of a Chinese family with congenital aniridia and to screen novel genetic mutations for congenital aniridia. Methods: All members of a three-generation family underwent comprehensive ophthalmic examination, and 8 of its 25 members were diagnosed with congenital aniridia. The proband was analyzed by exome sequencing and whole genome sequencing, and linkage analysis was performed for the family. The mutation was confirmed by direct DNA sequencing. Results: Using Illumina's Human Linkage-12 beadchip microarray (including 6090 SNPs) whole genome scan, the LOD score value showed that the interval on chromosome 11 between rs1389423 to rs910090 exhibited a strong linkage. A novel heterozygous 469 kb deletion mutation within the downstream region of PAX6 (chr11:31189937-31659379) was identified in all affected family members, but not in unaffected family members or 2000 ethnically matched controls. Conclusion: A novel deletion mutation was identified within the PAX6 downstream region that results in congenital aniridia.
What problem does this paper attempt to address?